Related Experiment Video
Updated: Jul 16, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Diarylheptanoid Phytoestrogen from Curcuma comosa Attenuates Colitis and Colitis-Associated Colorectal Cancer by
Van-Long Truong1,2, Razanamanana H G Rarison1,2, Eun-Ji Song3
1School of Food Science & Biotechnology, College of Agriculture and Life Sciences, Kyungpook National University, Daegu41566, Republic of Korea.
Abstract:
Diarylheptanoids are bioactive compounds primarily found in the rhizomes of Curcuma species and are traditionally used to treat inflammatory conditions. This study investigated the chemopreventive effects of 1,7-diphenyl-(4E, 6E)-4,6-heptadien-3-one (DPH), a diarylheptanoid isolated from Curcuma comosa ethanol extract (CCE), using in vitro and in vivo models. CCE/DPH administration significantly alleviated colitis and delayed colitis-associated colorectal tumorigenesis, accompanied by reduced expression of proinflammatory cytokines and mediators. Network pharmacology and experimental validation suggested potential involvement of the Toll-like receptor 4/mitogen-activated protein kinase/nuclear factor kappa B/signal transducer and activator of transcription 3 axis as a potential therapeutic target. Additionally, CCE/DPH upregulated the expression of the phase II antioxidant enzymes and tight junction proteins. Microbiome analysis revealed that CCE/DPH was associated with partial improvements in the gut microbial composition and metabolite profiles in experimental models. Overall, these findings support the preventive potential of CCE and DPH against experimental colitis and colitis-associated colorectal cancer.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Dysbiosis of the Gut Microbiota
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Ulcerative Colitis
Cancer Prevention
Some...
